Latest filing published 27 Mar 2026 for MEDIFAST INC, €1,653. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jonathan Barrett MacKenzie in Medifast Inc, where the filings describe the role as senior executive. Over a trading history stretching from 13 September 2021 to 13 March 2026, the count stands at 11 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 27 March 2026: a share grant of €1,653, in Medifast Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations